Skip Main Navigation
Page Content

Save This Event

Event Saved

Xconomy's EXOME Presents: What’s Hot in Cancer Immunotherapy 2017


Wednesday, June 14, 2017 at 1:30 PM (PDT)

Xconomy's EXOME Presents: What’s Hot in Cancer...

Ticket Information

Ticket Type Sales End Price Fee Quantity
Super Saver Rate Apr 12, 2017 $195.00 $4.89
Regular Registration Jun 14, 2017 $275.00 $6.49
Startup Special
For employees of startups less than 3 years old with 20 or fewer employees.
Jun 14, 2017 $125.00 $3.49
Student Registration
For full-time students only; limited number available. Valid student ID must be shown at registration desk.
Jun 14, 2017 $40.00 $1.79
At the Door Not Started $350.00 $7.95

Share Xconomy's EXOME Presents: What’s Hot in Cancer Immunotherapy 2017

Event Details

Xconomy's EXOME Presents: What's Hot in Cancer Immunotherapy

Seattle is one of the world's centers of cancer immunotherapy. Three years ago, Xconomy gathered some of the field's experts to talk about the promises of harnessing the immune system to fight cancer. Today, some of those promises seem well within reach, and a small but growing number of patients are benefiting from a handful of approved (and expensive) drugs. But while the opportunities seem closer at hand, many challenges remain. It's time to gather again in Seattle to discuss what's gone right, what's gone wrong, and how the field's brightest minds are working through the obstacles inherent when complicated biology, cutting-edge medical practice, and financial pressures meet.

Speakers from our last Seattle cancer immunotherapy event included:

  • Hans Bishop, CEO, Juno Therapeutics
  • Mitch Gold, Executive Chairman, Alpine BioSciences
  • Rob Hershberg, CEO, VentiRx Pharmaceuticals (now CSO at Celgene)
  • Deborah Law, VP, Biologics Discovery, Merck (now CSO at Jounce Therapeutics)
  • Ira Mellman, VP, Cancer Immunology, Genentech
  • Robert Nelsen, Managing Director, Arch Venture Partners
  • Stan Riddell, Researcher, Fred Hutchinson Cancer Research Center
  • Chad Robins, CEO, Adaptive Biotechnologies


Registration & Networking: 12:30 - 1:30 pm 
Program: 1:30 - 5:30 pm
Networking Reception: 5:30 - 6:30 pm 

Ticket Information:
Tickets are transferable but not refundable.
To inquire about press registration, email

*Speakers and program schedule are subject to change.

Fred Hutch

fenwick and West




 Alexandria Real Estate Equities

BioCrossroads • Davis Wright Tremaine
Fenwick & West • Texas Medical Center • UT Health San Antonio

ARCH Venture Partners • Santé Ventures

Acorda Therapeutics • Arrowhead Pharmaceuticals • Bayer
  Foundation Medicine • Genocea Biosciences • Health Advances

Have questions about Xconomy's EXOME Presents: What’s Hot in Cancer Immunotherapy 2017? Contact Xconomy

Save This Event

Event Saved

When & Where

Fred Hutchinson Cancer Research Center
Pelton Auditorium, Weintraub Building
1100 Fairview Ave. N
Seattle, WA 98109

Wednesday, June 14, 2017 at 1:30 PM (PDT)

  Add to my calendar



Xconomy is an innovative news and events organization with outposts in Boston, Boulder/Denver, Detroit/Ann Arbor, Indiana, New York, Raleigh-Durham, San Diego, San Francisco, Seattle, Texas, and Wisconsin. It is dedicated to providing business and technology leaders with timely, insightful, close-to-the-scene information about the local personalities, companies, and technological trends that best exemplify today’s high-tech economy. Xconomy is staffed by world-class journalists and media professionals, and supported by “the Xconomists,” who include some of the world’s leading innovators. Get to know them and the Xconomy team at

Sign up for RSS feeds, daily email newsletters, and email alerts from Xconomy at

  Contact the Organizer
Xconomy's EXOME Presents: What’s Hot in Cancer Immunotherapy 2017
Things to do in Seattle, WA Conference Science & Tech

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.